Vertex Trikafta Approved As First Triple Combo For Cystic Fibrosis With $311,503 Price Tag

The US FDA cleared the combination in just three months for patients with the most common genetic mutation. Company sets price above double regimen Symdeko, but in line with trailblazer Kalydeco.